Rahul Roychoudhuri

University of Cambridge — United Kingdom

Immunology and Microbiology · Life Sciences

41h-index9.3kcitations183works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(78), Immunotherapy and Immune Responses(49), T-cell and B-cell Immunology(42), CAR-T cell therapy research(40), Cancer Immunotherapy and Biomarkers(38)

Publications183 total

Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy
Nature Immunology·2026· 1 citedOpen Access
Local glucocorticoid signalling promotes pancreatic cancer
2025Open Access
Cortisol-resistant Chimeric Antigen Receptor (CAR)-NK cells overcome steroid-induced immunosuppression in lung cancer 9085
The Journal of Immunology·2025Open Access
Burning the candle at both ends: ROS-mediated telomere damage drives T cell dysfunction
Immunity·2025
Y-chromosome loss in cancer and immune cells might worsen treatment outcomes
Nature·2025
Perturbing local steroidogenesis to improve breast cancer immunity
Nature Communications·2025· 2 citedOpen Access
Drug repurposing reveals posaconazole as a CYP11A1 inhibitor enhancing anti-tumor immunity
iScience·2025Open Access
Supplementary Figure 2 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2025Open Access
Supplementary Figure 3 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2025Open Access
Supplementary Figure 1 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2025Open Access
Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity
Nature·2025· 70 citedOpen Access
Drug repurposing reveals Posaconazole as a CYP11A1 inhibitor enhancing anti-tumour immunity
2025· 2 citedOpen Access
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Nature Microbiology·2025· 28 citedOpen Access
Primitive steroidogenesis in mast cells: A novel regulatory mechanism for mast cell function
2025· 2 citedOpen Access
Inflammation and Cancer
Elsevier eBooks·2025
Primitive Steroidogenesis in Mast Cells: A Novel Regulatory Mechanism for Mast Cell Function
SSRN Electronic Journal·2025· 1 citedOpen Access
Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development
Frontiers in Immunology·2024· 5 citedOpen Access
Supplementary Figure 1 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 2 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
Supplementary Figure 1 from IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy
2024Open Access
page 1 of 10Next →

Frequent Co-authors

Nicholas P. Restifo(26), Luca Gattinoni(19), Christopher A. Klebanoff(17), Madhusudhanan Sukumar(16), Zhiya Yu(16), Douglas C. Palmer(16), Yun Ji(14), Robert Eil(12), David Clever(11), Klaus Okkenhaug(11), Joseph G. Crompton(9), Ena Wang(9), Francesco M. Marincola(9), Sarah K. Whiteside(8), Pawel Muranski(7), Shashank J. Patel(7), Francis M. Grant(7), Charlotte J. Imianowski(7), Jie Yang(7), Enrico Lugli(6)